|
| Attention UCI Researchers! The Recruitment Master Template is now available. | Are you conducting exempt or expedited research (i.e., minimal risk)? Does your study have multiple recruitment documents (e.g., email, flyer, webposting)? If your answer is “Yes,” the new Recruitment Master Template may be for you!
Effective May 1, 2023, when more than one recruitment material is to be used, the Recruitment Master Template (Word Document) should be submitted to the IRB for review. The IRB will stamp the completed master template as approved, but will not review or stamp any final versions of recruitment materials developed from an approved master template. Final versions of recruitment materials are to be maintained as part of the research record. These records may be requested by the IRB as part of a quality assurance process. IMPORTANT: Any subsequent change in the content of the master template that would also require a change to the approved protocol (i.e., eligibility criteria), must be submitted for IRB review and approval via an amendment.
Recruitment Master Template Eligibility Criteria: Exempt or Expedited Research; research is not FDA regulated.
How to Obtain IRB Approval: Upload a completed Recruitment Master Template with a new study or amendment submission in Kuali Research Protocols (KRP). |
|
| Update on Improving Fellowship Review: A Request for Information | NIH is recommending changes to the peer review of Ruth L. Kirschstein National Research Service Award (NRSA) fellowship applications by restructuring the review criteria. Read the full update on improving fellowship review.
Through the RFI, NIH continues to seek public comment on the proposed changes before moving forward with implementation. The RFI will be open for a 60-day period, until June 23, 2023. |
|
| Second Call for New Proposals: Basic and Translational Research Programs Requiring Wet Lab Space | There is a second call for new proposals for basic and translational research programs requiring wet lab space. This is a follow-up call to the original RFP in 2021. This call is for new proposals.
Please submit your proposals for research programs to Shauna Stark, starks@hs.uci.edu by Sept. 1, 2023. The School of Medicine’s Office of the Dean will reach out to you with recommendations for revision so they can be forwarded to the Office of the Vice Chancellor for Health Affairs by Oct. 15, 2023.
Deadline: Friday, Sept. 1, 2023 |
|
| Have You Received a New Award? | | Have you or someone on your research team received a new grant, i.e., research funding? The School of Medicine Office of Research would like to know! Please fill out this short New Funding/Grant Survey form. |
|
| Funding Opportunities Recently Added to Calendar |
| Call for Cancer Research Proposals | The UCI Cancer Research Institute is pleased to announce that funds are available through the American Cancer Society Institutional Research Grant. This institutional grant will fund several proposals for one year at a level up to $45,000 per award. All eligible faculty from each school at the University of California, Irvine are encouraged to apply, so long as the proposal has a clear link to some aspect of cancer research. The purpose of the seed grants is to provide pilot funds for research in both basic and clinical cancer-related problems.
Eligibility: Investigators within the first SIX years of their first independent faculty position and in the following series are eligible: In Line, In Residence, Adjunct, Clinical-X, Clinical and Researcher. Awardees may not hold a competitive grant from a national agency (e.g. NIH, ACS etc.) or be a previous recipient of an ACS-IRG seed grant. Questions regarding these criteria should be forwarded to Edward Nelson enelson@uci.edu and copy cri@uci.edu. Read more and apply here.
Deadline: Friday, May 26, 2023 by 5 p.m. |
|
| Call for Proposals: Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research | The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of coronary heart disease or circulatory failure prevention and improving care for these patients. The program focuses on basic and translational scientific research. Clinical studies are currently ineligible. Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.
UCI is one of only 14 institutions invited to participate in this program; three grants of $275,000/2 years ($150,000 in Year 1, and $125,000 in Year 2), will be awarded. All full-time faculty with combined federal and non-federal funding totaling $500,000 or less are eligible, and junior faculty are encouraged to apply. UCI may nominate only one candidate. Interested applicants may submit a preliminary application via the UCI Review system.
Deadline: Thursday, June 1, 2023 |
|
| Seed Funding Opportunity | The UCI Conte Center is soliciting applications for up to four grants. Each grant will be funded up to $30,000 for innovative basic and translational research projects focusing on brain plasticity, including how experiences may influence the brain and thus contribute to vulnerability to cognitive and mental illness.
We are seeking studies employing innovative concepts and/or cutting-edge methods. Proposals may involve human subjects or animal models or both. Projects employing molecular (including epigenetics and bioinformatics), cellular, circuit / systems or functional/behavioral in vivo approaches, in vivo imaging, or computational / modeling strategies and multidisciplinary approaches are welcome. Projects will be judged based on their significance, innovation and relevance to the goals of the UCI Conte Center. A few relevant key words: Unpredictable experiences, early-life adversity, the QUIC, anhedonia, brain circuit maturation, plasticity, learning and memory, emotional vulnerabilities. Read more about eligibility, application procedures and review process and criteria.
Applications will undergo review by a committee consisting of external referees and Center members. Awardees will be announced by July 1, 2023. Funds are for a one-year period. Requests may be for any amount up to and not exceeding $30,000. Awardees will provide a six-month interim report and a twelve-month final report. PI(s) will present their project and data to members of the Conte Center as well as participate in the Conte Center Annual Symposium. Questions should be directed to James Weinstock, jweinsto@uci.edu.
Deadline: Sunday, June 4, 2023, by 11:59 p.m. |
|
| Harrington Scholar-Innovator Award | Program goal: Recognizes outstanding physician-scientists whose work has potential to advance the standard of care. Seek breakthrough discoveries defined by innovation, creativity, and potential for clinical impact, including: Discoveries deemed to address unmet medical needs; Modulators of novel targets; Potential to be developed into a commercial program; Strong intellectual property (IP) or protection strategy; May be a small molecule, biologic, or other therapeutic modality; Diagnostics or devices only acceptable as part of a therapeutic development project. Eligibility: MD or MD/PhD (or equivalent) faculty member. Award Amount: $100K over two years with opportunity to qualify for up to $1,100,000. If you are interested in this opportunity, please reach out to Marianne Smith (mrsmith1@uci.edu) in the Corporate and Foundation Relations Group for assistance with your application! Read more here.
Letter of Intent Due Date: Monday, June 5, 2023 |
|
| Traumatic Brain Injury and Psychological Health Research Program (TBIPH) funding announcements | The Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) is part of the Congressionally Directed Medical Research Programs (CDMRP). The TBIPHRP has released five funding announcements for FY23. The TBIPHRP anticipates funding approximately 70 awards ranging from $500k total direct costs up to $5M total direct costs. Find additional information at the Electronic Biomedical Research Application Portal.
Pre-application Due Date: Early June 2023 |
|
| Michelson Next Gen Grants in Human Immunology (early career) | The 2023 Michelson Prizes are looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. Reviewers will be looking for research that is highly innovative and impactful, with the potential to be applied across many diseases. The $150,000 Michelson Prizes are awarded annually to support early-career investigators working to advance human immunology, vaccine discovery and immunotherapy research for major global diseases. Learn more about the Michelson Prizes: Next Generation Grants.
Deadline: Sunday, June 11, 2023 |
|
| Call for Proposals: Edward Mallinckrodt, Jr., Foundation Scholars Program | $225,000 over three years to support early stage investigators in their first to fourth year tenure-track positions by providing start-up support for basic biomedical (disease-related) research projects that are too preliminary for R01 or other independent funding.
Applicants with R01 funding should not apply. The mission of the Edward Mallinckrodt, Jr., Foundation (EMJF) is to support early stage investigators engaged in basic biomedical research that has the potential to advance the understanding, diagnosis or treatment of disease.
These grants are designed specifically to provide MD and/or PhD tenure track faculty members start up support to move the project forward to the point where R01 or other independent funding can be obtained. EMJF does not support projects that are already under way or are receiving significant grant support, nor does it provide funding beyond the initial three-year award.
UCI may forward one nomination. Therefore, interested applicants are asked to submit a preliminary application via the UCI Review system.
Deadline: Monday, June 12, 2023 |
|
| Vilcek Prizes for Creative Promise in Biomedical Science and Design | The Vilcek Foundation will award three prizes of $50,000 each to young biomedical scientists born outside of the US to non-American parents and who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science. Criteria for selection include demonstrated exceptional independence and creativity, and an ability to communicate the significance of their research to a general scientifically literate audience. Eligibility: Applicants must have been born outside the United States and be no more than 38 years old (born after January 1, 1985). All applicants must have earned a doctoral degree (M.D., Ph.D., or equivalent), intend to pursue a professional career in the United States, and hold a full-time position at an academic institution or other organization. Eligible positions include assistant or associate professor. Read more here.
Deadline: Monday, June 12, 2023 |
|
| Chan Zuckerberg Initiative (CZI): Collaborative Pairs Pilot Project Awards in Neurodegeneration and Neuroscience | The Chan Zuckerberg Initiative (CZI) invites letters of intent for the Collaborative Pairs Pilot Project Awards to support pairs of investigators and their teams to explore innovative, interdisciplinary approaches to address critical challenges in the neurodegenerative disease field and in areas of fundamental neuroscience such as the cellular, molecular and circuit mechanisms of cognition & memory and the neuroscience of sleep.
Awards are $200,000 in total costs per collaborating pair for a period of 18 months, after which successful projects will be eligible to apply for additional four-year acceleration grants that build on pilot phase studies. Collaborative Pairs teams will benefit from the support, mentoring and collaborative interactions of the CZI Neurodegeneration Challenge Network, as well as interactions with the broader CZ Science programs and grantee network.
Eligibility: Pairs from different institutions strongly encouraged; must not have received any funding previously to work together. At least one member of the pair must be early career (hired after June 22, 2017) or mid career (hired between June 22, 2013 and June 22, 2017). Register for the informational webinar on Wednesday, May 24, 2023, at 9 a.m.
Letter of Intents Deadline: Thursday, June 22, 2023, by 5 p.m. PT |
|
| ARPA-H launches its first research program: Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) | NITRO aims to address current issues surrounding osteoarthritis treatment by developing new ways of helping the human body repair its own joints. In particular, the program focuses on three technical areas: injectable bone regeneratives, injectable cartilage regeneratives, and replacement joints built from human cells.
To meet these goals, ARPA-H invites those interested in NITRO to read the full BAA and email ARPA-H about joining the program. Successful applicants will work with a diverse team of performers to address the biggest challenges facing osteoarthritis patients today. In doing so, NITRO performers may help reduce health costs, increase access, and drastically improve the lives of millions of people with or at risk for osteoarthritis.
Register for Proposers’ Day on Thursday, June 15, 2023, 6 a.m. to 3 p.m. Learn more about Proposers’ Day. Registration deadline is Thursday, June 8, 2023, 9 a.m. Based on evaluation of the abstract, ARPA-H may request a full proposal from BAA respondents.
Abstract Deadline: Friday, June 23, 2023, by 2 p.m. |
|
| Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) (PAR-23-177) | The National Center for Advancing Translational Sciences (NCATS) invites applications for the Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) Notice of Funding Opportunity (NOFO) to foster investigator-initiated development of highly innovative technologies to address barriers, limitations, or bottlenecks in translational science – particularly for therapeutic development.
This program will support the early-stage proof of concept, high-risk and potentially high-reward studies for feasibility and exploratory technology development, which can transform or significantly improve the efficiency of therapeutic development to achieve NCATS ultimate goals: more treatments to all people more quickly. The research proposed should be for the development of technology that can break new ground or extend present technology toward new directions or novel applications. With this initiative, we expect to support the development and/or prototyping of new technologies that will lead to improved efficiency in the therapeutic development pipeline. View the NOFO here.
Next available due date: Wednesday, July 19, 2023
Expiration date: June 20, 2025 |
|
| Upcoming Seminars & Events |
| Department of Biological Chemistry Seminar Series |
| 
Maryam Fallatah
Graduate Student
Peter Kaiser, PhD, Lab
UCI School of Medicine | 
Anna Andronicos
Graduate Student
Peter Kaiser, PhD, Lab
UCI School of Medicine | |
|
Join the Department of Biological Chemistry for the BC Seminar Series, featuring a Research in Progress graduate student presentation from Maryam Fallatah on A Small Molecule Corrector for p53 Mutants Found in Cancer, and Anna Andronicos on The Role of PP2A in Methionine Dependence of Cancer.
Wednesday, May 24, 11 a.m. to noon
Location: Plumwood House (Showa Denko Lecture Hall) at UCI
|
|
| Physiology & Biophysics Seminar Series: Shaista Malik, MD, PhD, MPH | Lecture: Mechanisms Underlying Acupuncture and Cardiovascular Regulation, by Shaista Malik, MD, PhD, MPH, professor, UCI School of Medicine; associate vice chancellor, UCI College of Health Sciences; executive director, Susan Samueli Integrative Health Institute.
Wednesday, May 24, 11 a.m. to noon
Hybrid event: Gross Hall Conference Center or via Zoom
|
|
| Microbiology & Molecular Genetics Wednesday Seminar Series 2023–24 | Lecture: Just one Bug or Spirits in a Microbial World, by Julie Parsonnet, MD, PhD, professor of medicine (Infectious Diseases and Geographic Medicine) and of Epidemiology and Population Health at Stanford University.
Wednesday, May 24, 4 p.m. PT
Location: Hybrid event at Plumwood House at UCI and telecast via Zoom
|
|
| Physiology & Biophysics: PhD Dissertation Defense by Andrew Wheat | Developing Advanced Cross-linking Mass Spectrometry Technologies to Study Protein-protein Interactions at the Systems Level, a PhD dissertation defense by Andrew Wheat, PhD candidate, Lan Huang Lab.
Thursday, May 25, 1 p.m. PT
Hybrid event: Nelson Auditorium at UCI or via Zoom
Meeting ID: 753 9675 6795
Passcode: gF0nUc
|
|
| Center for Translational Vision Research (CTVR) Ophthalmology Research Seminar: Distinguished Speaker Series | Retinal Implants by Mark S. Humayun, MD, PhD, Professor, Ophthalmology, Biomedical Engineering, and Integrative Anatomical Sciences, University of Southern California, Los Angeles, CA.
Friday, May 26, 8:30–9:30 a.m. PT
Location: In person at GHEI building, 3rd Floor, Cavanaugh Room, or via Zoom
Meeting ID: 944 8366 9170
Passcode: 745306 |
|
| UCI Center for Aging Research in Down Syndrome (CFAR-DS) Seminar Series with Dr. Beau Ances | Join the UCI Center for Aging Research in Down Syndrome (CFAR-DS) Seminar Series for this lecture on Alzheimer Disease in Down Syndrome: One extra chromosome, two extra hugs, by Beau Ances, MSc, MD, PhD, professor of neurology at Washington University in St. Louis.
Over the past 15 years, the Ances Bioimaging Laboratory (ABL) has focused on developing novel biomarkers for neurodegenerative diseases including HIV associated neurocognitive disorders (HAND), Alzheimer’s disease (AD), autoimmune encephalitis, and Down syndrome.
Friday, May 26, 11 a.m. PT
Location: Hybrid event at Herklotz Conference Room at UCI and via Zoom
|
|
| Physiology & Biophysics: PhD Dissertation Defense by Sharon Jan | PhD Dissertation Defense: Vaccine-induced adaptive T cell immunity enhances protective responses against Coxiella burnetii, by Sharon Jan, graduate student in Felgner Lab at UCI School of Medicine.
Friday, May 26, 1 p.m. PT
Location: Hybrid event at Thorp Conference Room, 4th Floor of Gross Hall and via Zoom
|
|
| Statistics Workshops, presented by Insight Research Services Associated | Insight Research Services Associated (an Australia-based company) is proud to be presenting workshops online in May through July 2023 at a time suitable for participants in North America. - May 30, June 2: Introduction to Survey Design B
- June 5-8: Introduction to Linear and Logistic Regression
- June 12-15: Introduction to Longitudinal Data Analysis
- July 17-20: Introduction to Structural Equation Modelling
Please note that these workshops will be held between 1 p.m. and 4 p.m. each day. There is a registration fee. These workshops are aimed at non-statisticians as well as statisticians new to these fields. For questions please contact Mark at m.griffin@insightrsa.com. Keep up to date with the training programs we deliver by joining our email list. Register and learn more about our workshops. |
|
| Microbiology & Molecular Genetics Wednesday Seminar Series 2023–24 |
| 
Orkide Koyuncu, PhD
Assistant Professor
Department of Microbiology & Molecular Genetics
UCI School of Medicine | 
Hannah Nam, MD, MSCI
Assistant Professor of Clinical Medicine
Department of Medicine, Division of Infectious Diseases
UCI School of Medicine | |
|
Lecture: Pathogens & You: A Change of Heart — Infections in Xenotransplantation, by Dr. Koyuncu and Dr. Nam.
Wednesday, May 31, 2 p.m. PT
Location: Hybrid event at Tamkin Hall F114 at UCI and telecast via Zoom
|
|
| MSTP Distinguished Lecture Series | Lecture: Deciphering and Targeting Clonal Evolution to Leukemia, by Ross L. Levine, MD, Laurence Joseph Dineen Chair in Leukemia Research; Deputy Physician-in-Chief, Translational Research, Memorial Hospital, Memorial Sloan Kettering Cancer Center.
Wednesday, May 31, 4 to 5 p.m.
Telecast via Zoom (register for details)
|
|
| Spring 2023 NSF Virtual Grants Conference – Registration is Open | Join the National Science Foundation (NSF) for the Spring 2023 NSF Virtual Grants Conference! This virtual conference will be broadcast live on Zoom. For those who cannot attend the live conference, all recorded conference sessions will be available on-demand shortly after the event and posted on the NSF website and YouTube page.
Monday to Thursday, June 5–8, 2023 |
|
| Research!America's Science and Technology Career Summit | This summit for early career researchers will feature a series of events designed to engage and equip them with tools for success. The sessions will provide early career researchers with the opportunity to explore an array of career paths, network with fellow researchers, participate in professional development workshops, and engage in meaningful discussions around issues critical to the success of the R&D ecosystem. - Session 1: Career Tour – 2 Panel Discussions with Early Career Professionals
Date: Wednesday, June 7, 2023, 9:30 a.m. to noon - Session 2: Mastering the Elevator Pitch
Date: Tuesday, June 13, 2023, 9:30 to 10:45 a.m. - Session 3: Communicating Science to Inspire and Foster Public Engagement
Date: Wednesday, June 14, 2023, 9:30 to 10:45 a.m. - Session 4: Building a Strong Resume: A Hiring Manager’s Perspective
Date: Wednesday, June 21, 2023, 9:30 to 11 a.m. - Session 5: Science and Startups: Taking your Research to the Next Level
Date: Wednesday, June 28, 2023, 9:30 to 10:45 a.m.
|
|
| CHOC Research Education: NIH Grant Writing: Funding Success Part 1 | Speakers: Sheila Cherry, PhD, and Jessica Lerch, PhD
Topics: - The Scientific Story
- Collaborative Research Teams
Wednesday, June 7, noon to 1:15 p.m.
|
|
| Information Session: Second Call for New Proposals | There is a second call for new proposals for basic and translational research programs requiring wet lab space. This is a follow-up call to the original RFP in 2021. This call is for new proposals.
Please join the information session to get your questions answered regarding this second call for applications. This is an open Q&A and information session about the call for new proposals for basic and translational research programs requiring wet lab space. Geoff Abbott, PhD, vice dean, Basic Research, will be leading the session to answer questions from faculty and attendees.
Please submit your proposals for research programs to Shauna Stark, starks@hs.uci.edu by Sept. 1, 2023. The School of Medicine’s Office of the Dean will reach out to you with recommendations for revision so they can be forwarded to the Office of the Vice Chancellor for Health Affairs by Oct. 15, 2023.
Information Session: Second Call for New Proposals
Wednesday, June 7, 2023, 1 to 2 p.m.
Meeting ID: 988 9522 9865; Passcode: 119577 |
|
| Physiology & Biophysics: Research in Progress Seminars |
| 
Lincy Antony
Graduate Student
Devon A. Lawson, PhD, Lab
Department of Physiology & Biophysics
UCI School of Medicine | 
Emily Silzel
Graduate Student
Phil Felgner, PhD, Lab
Department of Physiology & Biophysics
UCI School of Medicine | |
|
Join the Department of Physiology & Biophysics for their Research in Progress Seminars, featuring presentations by Lincy Antony on Immune Microenvironment Changes in BRCA1 Mutant Breast Cancer, and Emily Silzel on Lipid Nanoparticle Delivery of mRNA to the Murine Lymph Node.
Wednesday, June 7, 4 p.m. PT
Telecast via Zoom
Meeting ID: 917 4607 8598
|
|
| Faculty Development Series 2023 | Topic: How to Complete AP-10 Form (Clinical and Non-Clinical), with Kyoko Yokomori, PhD, associate dean for Academic Affairs; Nimisha K. Parekh, MD; and Brian J. Cummings, PhD.
Monday, June 12, 5:15–6:15 p.m.
Telecast via Zoom
|
|
| NCI Drug Development Workshop II: Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs | This workshop will encompass a series of six webinar-based lectures. They will address specialized topics that are important for the preclinical development of small molecule cancer drugs. The intention is to help investigators mitigate the translational risk of selected candidates during their later stages of product development and increase the chances of entering clinical evaluation. The intended audience is translational scientists who are interested in preclinical development of cancer drugs. Junior faculty, staff and trainees are encouraged to attend this workshop. Sessions start at 10 a.m. PT, and includes 60–90 minutes of lectures and 15 minutes of facilitated discussion. View the agenda for more information about this workshop.
June 22 to July 28, 2023, on selected Thursdays and Fridays, at 10 a.m. PT |
|
| CHOC Research Education: NIH Grant Writing: Funding Success Part 2 | Speakers: Sheila Cherry, PhD, and Jessica Lerch, PhD
Topics: - How to tailor your proposals to grant reviewers
- How to position your research and yourself to make reviewers your research advocates
Wednesday, July 19, noon to 1:15 p.m.
|
|
| Resource Roundup: Human Subjects, Clinical Trials and Inclusion | | Do you work with human subjects in your research? The NIH Division of Human Subjects Research (DHSR) team put together a handy one-page resource to help you find the information you need as you develop your grant application and beyond. Learn more about DHSR’s resource on human subjects, clinical trials and inclusion. |
|
| Learn More About UNITE’s Progress Towards Ensuring Equity and Opportunity in Biomedical Research | | The UNITE E Committee recently updated the research community on their progress toward creating a “multipronged strategy to advance racial equity and create the most inclusive biomedical research environment possible.” Learn more about their efforts on NIH’s website. |
|
| Update on Simplifying Review Criteria: Analysis of Comments from the Request for Information | | As discussed in the blog, “Update on Simplifying Review Criteria: A Request for Information (RFI),” NIH issued an RFI—from December 8, 2022, through March 10, 2023—seeking feedback on its proposed plan to revise and simplify the framework for the first level of the peer review of research project grant (RPG) applications. Learn more at NIH’s website. |
|
| Submitting for a UCOP funding opportunity? | | UCOP is not an internal sponsor because the funding originates from off-campus, so all UCOP projects need to be routed via the standard KR process. For questions, please direct to your Contract & Grants Analyst. |
|
| Are you considering applying for a Limited Funding Opportunities? | | In most cases, interested applicants submit a pre-proposal to the Office of Research where a committee reviews all submissions and makes a recommendation to the Vice Chancellor for Research about which proposal should go forward from UCI. Limited opportunities are advertised on fundopp.uci.edu with a link to apply. However, if you do not see a limited opportunity listed, please contact the Research Development Unit (somrd@hs.uci.edu). We can relay your application plans to the UCI Office of Research so they are aware of the number of interested PIs/units on campus and, if necessary, coordinate PIs or create a review process. |
|
| NIH Data Management and Sharing Policy Resources | NIH has released a new Data Management and Sharing Policy, effective Jan. 25, 2023, which requires the submission of a Data Management and Sharing Plan as part of all proposals for research that will generate scientific data. The NIH expects that the data generated will be shared broadly at the conclusion of the research. Researchers should plan now for the rollout of these requirements and develop Data Management and Sharing Plans that meet NIH expectations.
The following resources are available now for developing your plan: - The UCI School of Medicine Office of Research held an informational webinar on Tuesday, Nov. 8. View the recording and slides.
- The UCI Office of Research recently held an informational webinar on Tuesday, Jan. 10, 2023. View the recording here. The OR also released human subjects research consent language for the DMS policy.
- The NIH held a two-part webinar series. View the recordings and slide decks here
- Learn more about this new NIH policy here and in their recent posts here, here, and here. NIH also recently released sample DMS plans and information on how to budget for this new requirement.
- NIH released a number of blog posts-
- Post about how to comply with the Policy through eRA System Validation.
- Post about how to budget for personnel effort whose duties are part of the DMS plan.
- Post with information and resources on how to protect participant privacy.
- UCI Libraries has a wealth of resources on their page including the DMPTool and is available for 1:1 consultations.
|
|
| Updated Grants Preparation Material Request Form | | This Grants Preparation Material Request Form (previously the Boilerplate Request Form) has been updated to include numerous NIH templates and checklists (e.g., diversity supplements, RCR, K applications, and the PEDP). Save yourself time by taking advantage of these documents. Please view the form here, spread the word amongst your colleagues about this resource, and contact the Research Development Unit (somrd@hs.uci.edu) if you have any questions or suggestions. |
|
| What is Research Development? | Research Development encompasses strategic, proactive, and capacity-building activities designed to support individual faculty and teams of faculty in obtaining extramural research funding and also increase institutional competitiveness. The UCI School of Medicine Research Development Unit (RDU) meets individual faculty to provide information regarding research resources and assistance with grant proposals.
Do you want funding opportunities matching your research program automatically emailed to you? The RDU can also help you set up a Pivot account in minutes via Zoom and answer any questions you may have. Read more about Pivot and other funding search tools here. Reserve a slot here! |
|
| COVID-19 Reminders | With California’s COVID-19 state of emergency having ended on February 28, 2023, employees and students are reminded to continue to report their COVID-19 cases to Contact Tracing and Vaccine Navigation Services, which continues to investigate and contact trace cases. Free face coverings and antigen tests continue to be available on campus.
Please note that the end of the emergency does not mean the end of COVID-19, so individuals should continue to gauge their risk and take steps to protect themselves and their communities by staying up to date with vaccinations and boosters, staying home if sick, testing, washing hands and wearing masks when appropriate.
For the latest COVID-19 information, please visit the UCI Forward Website.
For UCI Health updates, please visit UCI HEALTH COVID-19 Updates. |
|
| Contribute to Research Insider! |
| |
|
